Chad J. Kolean serves as Executive at Cellectar Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Chad J. Kolean has executed 3 insider transactions totaling $24.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 2, 2025 involved purchasing 5,000 shares valued at $24.9K.
Chad J. Kolean currently holds 6,418 shares of Cellectar Biosciences, Inc. (CLRB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chad J. Kolean has been a net buyer of CLRB stock. They have purchased $24.9K and sold $0 worth of shares.
Chad J. Kolean's most recent insider trade was on Jul 2, 2025, when they purchased 5,000 shares at $4.99 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Apr 18, 2017 | CLRB | $0 | Award | 80,000 | $N/A | Discretionary |